baber/WOPTO huggingface dataset:
Patent AU-2019325652-A1 (AU)
Title: Alcohol concentrate filling systems and methods of use thereof
Inventor: LUKAC JURE
IPC: B67D1/00
Filed: 2019-08-23
Abstract: Disclosed herein are systems and methods for inducing a substantially non-hazardous atmosphere encompassing a beverage container during filling, such as filling a small volume container with an alcohol product. A multi-tiered approach can be used to reduce the combustibility of the atmosphere encompassing the beverage container. For example, a ventilation module can be provided and configured to dilute vapors of the beverage liquid. Further, a chilling module can be provided and configured to reduce or maintain a reduced temperature of the beverage liquid. Further, a capture module can be provided and configured to dilute stray beverage liquid. The ventilation module, the chilling module, and the capture module can cooperate to define a non-hazardous zone encompassing the beverage container. This can allow non-hazardous rated electrical components to operate proximate and within the atmosphere associating the alcohol product during filling.
Patent AU-2019326896-A1 (AU)
Title: Methods of normalizing amino acid metabolism
Inventor: REINER ALBERTO
IPC: A61P3/10
Filed: 2019-08-17
Abstract: Methods of normalizing amino acid metabolism in subjects on restricted protein diets and supplemental amino acids, using specially formulated amino acids that mimic the absorption and metabolism of naturally occurring proteins, are described.
Patent AU-2019330345-A1 (AU)
Title: Aqueous oral care solutions, methods, kits, and tooth surfaces having a coating derived from the oral care solution
Inventor: WANG YIZHONG
IPC: A61K8/21
Filed: 2019-08-27
Abstract: An aqueous oral care solution, a kit that includes such solution, a method of making such solution, a method of using such solution (e.g., a method of providing fluoride to a patient's tooth surface), and a tooth surface having a coating derived from the aqueous oral care solution, wherein the oral care solution includes: silver cations; thiocyanate anions provided by a thiocyanate source comprising Ca(SCN)2; fluoride anions; and water; wherein the molar ratio of silver to thiocyanate ions is up to 0.40:1, and water is up to 57 wt-%, based on the total weight of the solution.
Patent AU-2019341538-A1 (AU)
Title: Method for obtaining an enriched population of functional mesenchymal stem cells, cells obtained thereof and compositions comprising the same
Inventor: SÁNCHEZ GARCÍA ANA
IPC: C12N5/0775
Filed: 2019-09-18
Abstract: A method to obtain a composition comprising an enriched population of functional mesenchymal stem cells for hypothermic transport and local administration of said enriched population of functional mesenchymal stem cells in therapy. Finally also described is the use of said enriched population of functional mesenchymal stem cells, and compositions comprising them, obtained by the described method, in autologous or allogeneic treatment of diseases susceptible to mesenchymal stem cell therapy, either by local or systemic treatments, and more particularly in the treatment of osteoarticular diseases such as degenerative disc disease, osteoarthritis, and bone repair; in lupus erythematosus, graft-versus-host disease, and other autoimmune diseases; in peripheral vascular insufficiency and other cardiovascular diseases.
Patent AU-2019346545-A1 (AU)
Title: Ingestible device with expandable enclosure
Inventor: IMRAN MIR A
IPC: A61M99/00
Filed: 2019-09-24
Abstract: An embodiment of an ingestible device for the delivery of a therapeutic agent includes a swallowable outer shell and a delivery mechanism within the outer shell. The delivery mechanism includes an expandable enclosure. The delivery mechanism is triggerable in situ within a gastrointestinal (GI) tract of a body to expand multiple regions of the expandable enclosure to an expanded state at a delivery location within the body. The multiple regions include a head region and a tail region with a protective recess defined between the head region and the tail region, and a retention region within the protective recess. A dimension of the retention region as expanded is less than a dimension of the head region as expanded and less than a dimension of the tail region as expanded. The ingestible device includes a shaped composition disposed at the retention region.
Patent AU-2019347499-A1 (AU)
Title: Spinal disc replacements and methods of making thereof
Inventor: CORNEZ SCOTT DOUGLAS
IPC: A61F2/44
Filed: 2019-09-26
Abstract: A spine disc replacement composition, biocompatible support structure, and methods of fabricating the spine disc replacement and biocompatible support structure are provided. The spine disc replacement composition includes the biocompatible support structure that includes one or more of an annular ring, a first plate, or second plate of a biocompatible material and a tissue-engineered construct that includes a bio ink, where the annular ring includes an inner surface, an outer surface, a first planar surface, and a second planar surface, and the biocompatible material is present in an amount of about 1% to about 100% by weight of the biocompatible support structure.
Patent AU-2019360638-A1 (AU)
Title: Dosage regime
Inventor: O'NEIL DEBORAH
IPC: A61P11/00
Filed: 2019-10-17
Abstract: The present disclosure relates to use of cysteamine, formulations comprising cysteamine and pharmaceutically acceptable salts of cysteamine in the treatment of cystic fibrosis and conditions associated with cystic fibrosis.
Patent AU-2019362088-A1 (AU)
Title: Privacy preserving validation and commit architecture
Inventor: BLEIKERTZ SÖREN GERHARD
IPC: H04L9/08
Filed: 2019-10-21
Abstract: A method (400) of scheduling and validating a multiple-participant process, the method comprising: submitting (420), by a submitting node (210) associated with a participant in the multiple-participant process, a proposed transaction by sending a cryptographically-protected message (140) to one or more recipient nodes (120, 122), wherein the cryptographically-protected message (140) comprises at least an unencrypted submessage (142) readable by an external node (130) and a cryptographically-protected submessage (144) to preserve privacy from at least the external node (130); determining (410), by the external node, an order of the proposed transaction relative to other transactions; by way of at least some of the recipient nodes, validating the cryptographically-protected message; receiving (440) a confirmation of validity of the cryptographically-protected message from at least some of the recipient nodes; finalizing (450) the proposed transaction, as a confirmed transaction, based on receiving one or more confirmations from at least some of the recipient nodes that satisfy a confirmation condition; and writing (460) the confirmed transaction to a distributed ledger according to the order determined by the external node.
Patent AU-2019372717-A1 (AU)
Title: Display control system, display control method and remote operation system
Inventor: DING QI
IPC: E02F9/26
Filed: 2019-10-30
Abstract: A captured image acquisition unit acquires a captured image captured by an imaging device mounted on a work vehicle. An attitude image acquisition unit acquires an attitude image which indicates the roll angle and/or pitch angle of the work vehicle. A display image generation unit generates a display image in which the attitude image is arranged on the captured image such that the attitude image is displayed in a position opposite of the driver seat in the width direction of a display device. A display control unit outputs onto the display device a display signal for displaying the display image.
Patent AU-2019381793-A1 (AU)
Title: Compounds for use as iron (III) MRI contrast agents containing anionic pendents and ancillary groups
Inventor: MORROW JANET R
IPC: C07D255/02
Filed: 2019-11-18
Abstract: Macrocyclic complexes and macrocyclic compounds. The macrocyclic complexes or macrocyclic compounds have a TACN moiety with one or more amine group(s) or a O- or S- substituted TACN moiety. The macrocyclic complexes have a high-spin Fe(III) atom coordinated to the TACN moiety. The macrocyclic complexes can be used in imaging methods.
Patent AU-2019464932-A1 (AU)
Title: Variable climate zone compartment
Inventor: PAGNOZZI RODRIGO MARGE
IPC: F25D17/06
Filed: 2019-09-04
Abstract: A refrigeration appliance including a compartment for storing food items. A partition divides the compartment into a first and a second compartments. The first compartment is disposed horizontally adjacent the second compartment and has a user-selectable target freezer temperature. An evaporator is disposed in the first compartment. An evaporator fan is disposed in the first compartment for conveying cooling air from the evaporator to the first and the second compartments. A temperature control module positioned in the second compartment. The temperature control module includes a body having front and rear surfaces. An air passage is formed in the body and extends between a side inlet opening of the body to at least one outlet opening on the front surface of the body. A heater assembly is disposed between the front and the rear surfaces of the body for heating air in the air passage.
Patent AU-2019472374-A1 (AU)
Title: Dispenser for rolls of absorbent paper material
Inventor: ELLIOTT ADAM T
IPC: A47K10/38
Filed: 2019-10-30
Abstract: A dispenser for housing at least two rolls of rolled up absorbent paper material, the dispenser (1) comprising a mandrel member (20) comprising two roll supports (22, 24); and a housing (10), the dispenser (1) being configured such that the roll supports (22, 24) can assume the following positions relative to the housing (10): at least one dispensing position (12) for a roll support of said two roll supports (22, 24), and a storage position (14) for a roll support of said two roll supports (22, 24), the dispenser (1) being configured for allowing dispensing from a roll (2) of material arranged on a roll support of said two roll supports (22, 24) which is in said dispensing position (12) and for storage of a roll (2') arranged on a roll support of said two roll supports (22, 24) which is in said storage position (14); said dispenser (1) being configured to provide a first state, wherein a first roll support (22) of said roll supports (22, 24) is in said dispensing position (12) and a second roll support (24) of said roll supports (22, 24) is in said storage position (14), and a second state, wherein said second roll support (24) is in a dispensing position (12'), and said first roll support (22) is in another position than said storage position (14), wherein the mandrel member (20) defines a guide member (26) along which the two roll supports (22, 24) are movable relative to each other such that the mandrel member (20) displays an extended condition and a collapsed condition, wherein a minimum distance (L) between the roll support axes between the two roll supports (22, 24) is shorter in said collapsed condition than in said extended condition, and in the first state, the mandrel member (20) is in said extended condition, and in the second state, the mandrel member (20) is in said collapsed condition. The disclosure further relates to a mandrel and a method for replenishing a dispenser.
Patent AU-2020204412-A1 (AU)
Title: Stretch valve balloon catheter and methods for producing and using same
Inventor: PINCHUK LEONARD
IPC: A61M27/00
Filed: 2020-07-01
Abstract: A safety balloon catheter includes a catheter having a stretch valve, a connector, a balloon inflated 
with an inflation fluid, a hollow inflation lumen extending through the catheter to the balloon and 
conveying inflation fluid thereto and therefrom, a hollow second lumen, and a balloon drainage port 
fluidically connecting the balloon to the second lumen. The stretch valve has a NA hollow base fixed 
in the second lumen at a proximal catheter end and shaped to permit a fluid therethrough and a 
hollow plug slidably positioned in the second lumen at a given distance from the base to, in a steady 
state, prevent inflation fluid from passing through the drainage port and, when actuated, slide within 
the second lumen to permit inflation fluid to pass through the drainage port and into the second 
lumen. The connector connects the base and the plug and has a length greater than the given distance.
Patent AU-2020234831-A1 (AU)
Title: Pictures with mixed NAL unit types
Inventor: WANG YE-KUI
IPC: H04N19/00
Filed: 2020-03-11
Abstract: A video coding mechanism is disclosed. The mechanism includes receiving a bitstream comprising a plurality of sub-pictures associated with a picture and a flag. The sub-pictures are contained in a plurality of video coding layer (VCL) network abstraction layer (NAL) units. A NAL unit type value is the same for all VCL NAL units associated with the picture when the flag is set to a first value. When the flag is set to a second value, a first NAL unit type value for VCL NAL units containing one or more of the sub-pictures of the picture is different than a second NAL unit type value for VCL NAL units containing one or more of the sub-pictures of the picture. The sub-pictures are decoded based on the NAL unit type values. The sub-pictures are forwarded for display as part of a decoded video sequence.
Patent AU-2020244497-A1 (AU)
Title: Using programmable dna binding proteins to enhance targeted genome modification
Inventor: CHEN FUQIANG
IPC: G01N33/58
Filed: 2020-09-30
Abstract: Compositions and methods for using programmable DNA binding proteins to increase the 
efficiency and/or specificity of targeted genome modification or to facilitate the detection of 
specific genomic loci in eukaryotic cells.
Patent AU-2020251273-A1 (AU)
Title: Systems and methods of detecting incorrect connections in a humidification system
Inventor: TENG IVAN CHIH-FAN
IPC: A61M16/16
Filed: 2020-03-27
Abstract: Various control methods can indirectly determine incorrect connections between components in a respiratory therapy system. For example, incorrect connections can occur between a patient interface, a humidifier and/or a gases source. The methods can indirectly detect if reverse flow conditions or other error conditions exist. A reverse flow condition can occur when gases flows in a direction different from an intended direction of flow. The methods can be implemented at the humidifier side, at the gases source side, or both.
Patent AU-2020254391-A1 (AU)
Title: Dunnage conversion machine, method, and product with a polygonal cross-section
Inventor: CHEICH ROBERT C
IPC: B31D5/00
Filed: 2020-03-12
Abstract: A machine for converting a sheet material into a relatively less dense dunnage product includes a forming assembly and a feeding assembly downstream of the forming assembly. The forming assembly is configured to form the sheet material into a tubular shape with lateral edges of the sheet material adjacent one another. A deflector at a downstream end of the forming assembly is configured to engage the lateral edges of the sheet material and to urge the lateral edges into an interior of the tubular shape. This juxtaposes lateral edge portions of the sheet material adjacent the respective lateral edges. A forming channel at a downstream end of the forming assembly faces the deflector to receive the lateral edge portions and shape them into a tab. Finally, the feeding assembly includes rotating connecting members that engage and connect the overlapping lateral edge portions of the sheet material forming the tab.
Patent AU-2020254610-A1 (AU)
Title: Inhibitors of aldose reductase
Inventor: WASMUTH ANDREW
IPC: A61K31/5025
Filed: 2020-03-31
Abstract: The present disclosure relates to novel compounds and pharmaceutical compositions thereof, and methods for promoting healthy aging of skin, the treatment of skin disorders, the treatment of cardiovascular disorders, the treatment of renal disorders, the treatment of angiogenesis disorders, such as cancer, treatment of tissue damage, such as non-cardiac tissue damage, the treatment of evolving myocardial infarction, the treatment of ischemic injury, and the treatment of various other disorders, such as complications arising from diabetes with the compounds and compositions of the invention. Other disorders can include, but are not limited to, atherosclerosis, cardiomyopathy, coronary artery disease, diabetic nephropathy, diabetic neuropathy, diabetic retinopathy, diabetic cardiomyopathy, infections of the skin, peripheral vascular disease, stroke, galactosemia, asthma, PMM2-CDG and the like.
Patent AU-2020277114-A1 (AU)
Title: Clothes treating apparatus
Inventor: WON KWANGJAE
IPC: D06F58/24
Filed: 2020-11-24
Abstract: Disclosed is a clothes treating apparatus including a drum accommodating an 
object to be dried, a tub including the drum, a first drying duct communicating with an 
inner side of the drum at one side and an inner side of the tub at the other side, a 
circulation fan disposed in an end portion of the other side of the first drying duct to 
circulate air, a spray nozzle disposed between the circulation fan and the drum to 
spray cooling water to a space between the tub and the drum, a water collecting 
container disposed below the tub to collect cooling water, a circulation line supplying 
the cooling water to the spray nozzle, a drainage line discharging the cooling water to 
outside, and a flow-path conversion pump receiving the cooling water from the water 
collecting container and supplying the cooling water selectively to the circulation line 
or the drainage line.  
90845454.2
FIG.2 
110 120 101 130 135 140 150 
133 
131 
170 
102 
180 
/ /I / / /Z / 1 /7 
161 160 200
Patent AU-2020283537-A1 (AU)
Title: Modified viral particles and uses thereof
Inventor: SABIN LEAH
IPC: A61K48/00
Filed: 2020-05-22
Abstract: Provided herein are compositions and methods for adapting adeno-associated virus (AAV) particles comprising capsids of non-primate animal AAV, remote AAV, or a combination thereof. AAV adapted accordingly may be a viable gene therapy platform for the treatment of a patient in need thereof, and may be particularly useful in patients excluded from current treatment modalities involving current therapeutic AAV particles due to their high titer of antibodies against the current therapeutic AAV particles.
Patent AU-2020291487-A1 (AU)
Title: Bispecific antibody against alpha-syn/IGF1R and use thereof
Inventor: AN SUNGWON
IPC: A61P25/28
Filed: 2020-06-15
Abstract: The present specification relates to a bispecific antibody that specifically binds to α-synuclein and IGF1R, and to a use of the bispecific antibody in preventing, treating and/or diagnosing synucleinopathy, which is a disease associated with α-synuclein or aggregates thereof. The bispecific antibody enables an α-syn antibody or an antigen-binding fragment thereof to pass through the blood-brain barrier and exert an action of the antibody or the fragment in the brain, and extends the half-life thereof, thereby allowing drug efficacy to sustain for a long time.
Patent AU-2020310020-A1 (AU)
Title: Vacuum adiabatic body and refrigerator
Inventor: KIM BONGJIN
IPC: F16L59/12
Filed: 2020-07-09
Abstract: Provided is a vacuum adiabatic body. The vacuum adiabatic body includes an outer case made of a metal material, which is thicker than a plate providing a vacuum space. The vacuum space provides two extension modules that extend in directions different from each other. Accordingly, a refrigerator door may be improved in adiabatic performance.
Patent AU-2020319022-A1 (AU)
Title: Orodispersible powder composition comprising a triptan
Inventor: AGELL PUIG FRANCESC
IPC: A61K9/14
Filed: 2020-07-15
Abstract: The present invention relates to an orodispersible powder composition comprising a triptan and a ternary synergistic combination of sodium citrate, citric acid and sucralose. It also relates to a stick pack comprising such powder composition, and its use in the treatment of migraine.
Patent AU-2020325307-A1 (AU)
Title: Sector variable time gain compensation
Inventor: SCHAFER MARK E
IPC: G01S7/52
Filed: 2020-08-07
Abstract: Ultrasound systems having a computing device, a steering mechanism, and an ultrasound transducer are disclosed. The ultrasound transducer is configured to generate angularly discrete signals over a scan region of the ultrasound system in response to inputs from the steering mechanism. The computing device is communicatively coupled to the ultrasound transducer. The computing device includes a processor configured to receive angularly discrete ultrasound signals from the ultrasound transducer over the scan region, determine a scan line count corresponding to each of the received angularly discrete ultrasound signals, associate a TGC curve with each of the scan line counts, apply a TGC curve to each of the angularly discrete ultrasound signals as associated with the scan line count of each angularly discrete ultrasound signal, where each of the applied TGC curves defines a gain that maintains, increases, or decreases the angularly discrete ultrasound signal to which it is applied, over time.
Patent AU-2020338049-A1 (AU)
Title: Adjustment means for a mandibular advancement device
Inventor: MORGAN OWEN
IPC: A61C7/06
Filed: 2020-08-26
Abstract: The present invention is an adjustment means for a mandibular advancement device, having both intraoral and extraoral portions, including a body portion at the interface. The extraoral portion includes a lower arm and a curved upper arm. The posterior end of the upper arm includes a pad assembly that is adapted to make contact with and apply pressure to the subnasal maxillary bone. The lower arm includes a thread that is adapted to be threaded into an adjustment wheel so that turning in one direction causes the extraoral portion to retract into the body portion, causing the upper pad to apply greater pressure to the subnasal maxillary bone. Turning the adjustment wheel in the opposite direction causes the upper pad to apply decreased pressure. One complete revolution of the adjustment wheel in a first or second direction causes the extraoral portion to extend or retract by one millimetre in length.
Patent AU-2020356534-A1 (AU)
Title: Process for the production of 5-(4-((2S,5 S)-5-(4-chlorobenzyl)-2-methylmorpholino)piperidin-1-Yl)-1 H-1,2,4-triazol-3-amine
Inventor: WITKOWSKI GRZEGORZ
IPC: C07D413/14
Filed: 2020-09-25
Abstract: The present invention relates to a process for the synthesis of 5-(4-((2S,5S)-5-(4-chlorobenzyl)- 2-methylmorpholino)piperidin-1-yl)-1
Patent AU-2020459746-A1 (AU)
Title: Dual cytokine fusion proteins comprising IL-10
Inventor: MUMM JOHN
IPC: C07K16/28
Filed: 2020-12-02
Abstract: The application relates to a dual cytokine fusion protein composition, pharmaceutical composition, and/or formulation thereof comprising IL-10 or IL-10 variant molecules fused to a single chain variable fragment scaffolding system and a second cytokine, where the second cytokine is linked in the hinge region of the scFv. The application also relates to methods of using the dual cytokine fusion protein composition for treating cancer, inflammatory diseases or disorders, and immune and immune mediated diseases or disorders.
Patent WO-2021232106-A1 (WO)
Title: Excavation inspection and clearance system
Inventor: CRONIN JOE
IPC: G05D1/00
Filed: 2021-05-20
Abstract: An excavation inspection and clearance method and system is provided. The method comprises: navigating the excavation with one or more autonomous agents; searching, using one or more sensors of the autonomous agents, for persons and/or equipment in proximity of the autonomous agent while navigating the excavation; and determining clear zones around each of the one or more autonomous agents according to a lack of persons and/or equipment in proximity of the autonomous agents while navigating the excavation. The one or more autonomous agents are configured to navigate the excavation such that the clear zones are maintained and can be joined to form a larger clear zone in the excavation..